$121 Million is the total value of Worth Venture Partners, LLC's 96 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | CAESARS ENTMT CORPnote 5.000%10/0 | $13,616,000 | – | 8,004,000 | +100.0% | 11.26% | – | |
| New | HERBALIFE LTDnote 2.000% 8/1 | $5,142,000 | – | 3,971,000 | +100.0% | 4.25% | – | |
| ILMN | New | ILLUMINA INC | $3,422,000 | – | 12,252 | +100.0% | 2.83% | – |
| New | TESARO INCnote 3.000%10/0 | $2,331,000 | – | 1,550,000 | +100.0% | 1.93% | – | |
| New | EURONET WORLDWIDE INCnote 1.500%10/0 | $2,315,000 | – | 1,890,000 | +100.0% | 1.91% | – | |
| New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $1,518,000 | – | 1,695,000 | +100.0% | 1.26% | – | |
| WDC | New | WESTERN DIGITAL CORP | $1,443,000 | – | 18,634 | +100.0% | 1.19% | – |
| AXP | New | AMERICAN EXPRESS CO | $1,349,000 | – | 13,763 | +100.0% | 1.12% | – |
| AGX | New | ARGAN INC | $543,000 | – | 13,270 | +100.0% | 0.45% | – |
| KMX | New | CARMAX INC | $528,000 | – | 7,250 | +100.0% | 0.44% | – |
| XLRN | New | ACCELERON PHARMA INC | $491,000 | – | 10,117 | +100.0% | 0.41% | – |
| KN | New | KNOWLES CORP | $339,000 | – | 22,128 | +100.0% | 0.28% | – |
| GIB | New | GROUPE CGI INCcl a sub vtg | $322,000 | – | 5,089 | +100.0% | 0.27% | – |
| MA | New | MASTERCARD INCORPORATEDcl a | $318,000 | – | 1,620 | +100.0% | 0.26% | – |
| NBR | New | NABORS INDUSTRIES LTD | $302,000 | – | 47,064 | +100.0% | 0.25% | – |
| MERC | New | MERCER INTL INC | $268,000 | – | 15,340 | +100.0% | 0.22% | – |
| BBT | New | BB&T CORP | $267,000 | – | 5,290 | +100.0% | 0.22% | – |
| DLTR | New | DOLLAR TREE INC | $255,000 | – | 3,000 | +100.0% | 0.21% | – |
| OMAB | New | GRUPO AEROPORTUARIO CTR NORTspon adr | $252,000 | – | 6,050 | +100.0% | 0.21% | – |
| LSTR | New | LANDSTAR SYS INC | $205,000 | – | 1,875 | +100.0% | 0.17% | – |
| AKRXQ | New | AKORN INC | $172,000 | – | 10,339 | +100.0% | 0.14% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INput | $113,000 | – | 18,000 | +100.0% | 0.09% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INCput | $83,000 | – | 29,500 | +100.0% | 0.07% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $78,000 | – | 29,500 | +100.0% | 0.06% | – |
| AXP | New | AMERICAN EXPRESS COput | $68,000 | – | 31,000 | +100.0% | 0.06% | – |
| ILMN | New | ILLUMINA INCcall | $54,000 | – | 6,200 | +100.0% | 0.04% | – |
| ILMN | New | ILLUMINA INCput | $41,000 | – | 8,400 | +100.0% | 0.03% | – |
| AKRXQ | New | AKORN INCput | $29,000 | – | 27,500 | +100.0% | 0.02% | – |
| VTL | New | VITAL THERAPIES INCput | $26,000 | – | 15,100 | +100.0% | 0.02% | – |
| PF | New | PINNACLE FOODS INC DELcall | $23,000 | – | 22,400 | +100.0% | 0.02% | – |
| WDC | New | WESTERN DIGITAL CORPput | $13,000 | – | 11,000 | +100.0% | 0.01% | – |
| ACOR | New | ACORDA THERAPEUTICS INCput | $10,000 | – | 10,800 | +100.0% | 0.01% | – |
| XLRN | New | ACCELERON PHARMA INCput | $9,000 | – | 22,300 | +100.0% | 0.01% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $5,000 | – | 1,200 | +100.0% | 0.00% | – |
| SFL | New | SHIP FINANCE INTERNATIONAL Lput | $5,000 | – | 50,000 | +100.0% | 0.00% | – |
| KMX | New | CARMAX INCput | $3,000 | – | 3,900 | +100.0% | 0.00% | – |
| HRTX | New | HERON THERAPEUTICS INCput | $1,000 | – | 15,000 | +100.0% | 0.00% | – |
| VTL | New | VITAL THERAPIES INCcall | $1,000 | – | 2,100 | +100.0% | 0.00% | – |
| AVEO | New | AVEO PHARMACEUTICALS INCput | $0 | – | 100 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AIRGAIN ORD | 25 | Q3 2023 | 1.8% |
| PIXELWORKS ORD | 23 | Q3 2022 | 1.3% |
| SILICOM ORD | 22 | Q3 2023 | 1.8% |
| DSP GROUPS INC | 20 | Q3 2021 | 1.4% |
| DIGITAL TURBINE ORD | 19 | Q2 2023 | 1.0% |
| BK OF AMERICA CORP | 17 | Q3 2023 | 1.1% |
| EQUITY COMWLTH REIT ORD | 17 | Q3 2023 | 0.7% |
| ISHARES TR | 16 | Q4 2020 | 3.0% |
| SCPHARMACEUTICALS ORD | 16 | Q3 2023 | 2.8% |
| SELECT SECTOR SPDR TR | 16 | Q4 2020 | 1.3% |
View Worth Venture Partners, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Worth Venture Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.